Journal article
High-dose vs standard-dose influenza vaccine in older adults with diabetes: a secondary analysis of the DANFLU-2 Randomized Clinical Trial
- Abstract:
-
Importance: Influenza infection poses a substantial risk of severe complications, particularly in older adults and high-risk populations, such as individuals with diabetes. The high-dose inactivated influenza vaccine (HD-IIV) has demonstrated superior efficacy against influenza infection compared with the standard-dose inactivated influenza vaccine (SD-IIV) among adults 65 years or older. However, there is limited evidence on its effectiveness in preventing severe respirat...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 434.3KB, Terms of use)
-
- Publisher copy:
- 10.1001/jamainternmed.2025.7286
Authors
- Publisher:
- American Medical Association
- Journal:
- JAMA Internal Medicine More from this journal
- Publication date:
- 2026-01-12
- Acceptance date:
- 2025-11-12
- DOI:
- EISSN:
-
2168-6114
- ISSN:
-
2168-6106
- Language:
-
English
- Keywords:
- Pubs id:
-
2330100
- Local pid:
-
pubs:2330100
- Deposit date:
-
2025-11-20
- ARK identifier:
Terms of use
- Copyright holder:
- Nielsen et al
- Copyright date:
- 2026
- Rights statement:
- © 2026 Nielsen AB et al. This is an open access article distributed under the terms of the CC-BY-NC-ND License, which does not permit alteration or commercial use, including those for text and data mining, AI training, and similar technologies.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record